| Outgoing Relation(s) |
| platelet aggregation inhibitor (CHEBI:50427) is a hematologic agent (CHEBI:50248) |
| Incoming Relation(s) |
| (±)-suloctidil (CHEBI:233445) has role platelet aggregation inhibitor (CHEBI:50427) |
| (E)-2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside (CHEBI:140850) has role platelet aggregation inhibitor (CHEBI:50427) |
| (E)-3-tosylacrylonitrile (CHEBI:85928) has role platelet aggregation inhibitor (CHEBI:50427) |
| (S)-glaucine (CHEBI:5373) has role platelet aggregation inhibitor (CHEBI:50427) |
| N-tert-butyl(3,5,6-trimethylpyrazin-2-yl)methanimine N-oxide (CHEBI:133247) has role platelet aggregation inhibitor (CHEBI:50427) |
| N-trans-cinnamoyltyramine (CHEBI:177872) has role platelet aggregation inhibitor (CHEBI:50427) |
| S-nitroso-L-cysteine (CHEBI:138935) has role platelet aggregation inhibitor (CHEBI:50427) |
| S-nitrosoglutathione (CHEBI:50091) has role platelet aggregation inhibitor (CHEBI:50427) |
| cis-ferulic acid (CHEBI:76117) has role platelet aggregation inhibitor (CHEBI:50427) |
| 12-HPEPE (CHEBI:78909) has role platelet aggregation inhibitor (CHEBI:50427) |
| 12-HPEPE(1−) (CHEBI:78078) has role platelet aggregation inhibitor (CHEBI:50427) |
| 2-acetamidophenol (CHEBI:143107) has role platelet aggregation inhibitor (CHEBI:50427) |
| 4-phenyl-3-furoxancarbonitrile (CHEBI:180495) has role platelet aggregation inhibitor (CHEBI:50427) |
| 4,4'-dihydroxybenzyl sulfone (CHEBI:65786) has role platelet aggregation inhibitor (CHEBI:50427) |
| 6-oxoprostaglandin E1 (CHEBI:28269) has role platelet aggregation inhibitor (CHEBI:50427) |
| acadesine (CHEBI:28498) has role platelet aggregation inhibitor (CHEBI:50427) |
| acetylsalicylic acid (CHEBI:15365) has role platelet aggregation inhibitor (CHEBI:50427) |
| ACT-333679 (CHEBI:90848) has role platelet aggregation inhibitor (CHEBI:50427) |
| actinodaphnine (CHEBI:2444) has role platelet aggregation inhibitor (CHEBI:50427) |
| aglafolin (CHEBI:65374) has role platelet aggregation inhibitor (CHEBI:50427) |
| anagrelide (CHEBI:142290) has role platelet aggregation inhibitor (CHEBI:50427) |
| anagrelide hydrochloride (CHEBI:55345) has role platelet aggregation inhibitor (CHEBI:50427) |
| angelitriol (CHEBI:132402) has role platelet aggregation inhibitor (CHEBI:50427) |
| angelol-J (CHEBI:132768) has role platelet aggregation inhibitor (CHEBI:50427) |
| asperenone (CHEBI:133813) has role platelet aggregation inhibitor (CHEBI:50427) |
| AT-1015 hydrochloride (CHEBI:228366) has role platelet aggregation inhibitor (CHEBI:50427) |
| AT-1015 hydrochloride monohydrate (CHEBI:234343) has role platelet aggregation inhibitor (CHEBI:50427) |
| azelastine (CHEBI:2950) has role platelet aggregation inhibitor (CHEBI:50427) |
| azelastine hydrochloride (CHEBI:2951) has role platelet aggregation inhibitor (CHEBI:50427) |
| bassiatin (CHEBI:65465) has role platelet aggregation inhibitor (CHEBI:50427) |
| BAY 41-2272 (CHEBI:142435) has role platelet aggregation inhibitor (CHEBI:50427) |
| benzo[d]isothiazol-3-one (CHEBI:167099) has role platelet aggregation inhibitor (CHEBI:50427) |
| beraprost (CHEBI:135633) has role platelet aggregation inhibitor (CHEBI:50427) |
| beraprost sodium (CHEBI:31270) has role platelet aggregation inhibitor (CHEBI:50427) |
| bianfugenine (CHEBI:132719) has role platelet aggregation inhibitor (CHEBI:50427) |
| bis-(4-hydroxybenzyl)ether (CHEBI:65501) has role platelet aggregation inhibitor (CHEBI:50427) |
| cangrelor (CHEBI:90841) has role platelet aggregation inhibitor (CHEBI:50427) |
| cangrelor tetrasodium (CHEBI:90836) has role platelet aggregation inhibitor (CHEBI:50427) |
| carmoxirole (CHEBI:64200) has role platelet aggregation inhibitor (CHEBI:50427) |
| carmoxirole hydrochloride (CHEBI:64199) has role platelet aggregation inhibitor (CHEBI:50427) |
| cilostazol (CHEBI:31401) has role platelet aggregation inhibitor (CHEBI:50427) |
| clonixin (CHEBI:76200) has role platelet aggregation inhibitor (CHEBI:50427) |
| clonixin lysine salt (CHEBI:76201) has role platelet aggregation inhibitor (CHEBI:50427) |
| clopidogrel (CHEBI:37941) has role platelet aggregation inhibitor (CHEBI:50427) |
| clopidogrel sulfate (CHEBI:3759) has role platelet aggregation inhibitor (CHEBI:50427) |
| cyclomorusin A (CHEBI:132868) has role platelet aggregation inhibitor (CHEBI:50427) |
| cytochalasin B (CHEBI:23527) has role platelet aggregation inhibitor (CHEBI:50427) |
| diallyl trisulfide (CHEBI:78492) has role platelet aggregation inhibitor (CHEBI:50427) |
| dilazep (CHEBI:92842) has role platelet aggregation inhibitor (CHEBI:50427) |
| dilazep dihydrochloride (CHEBI:31493) has role platelet aggregation inhibitor (CHEBI:50427) |
| dipyridamole (CHEBI:4653) has role platelet aggregation inhibitor (CHEBI:50427) |
| dithiadene (CHEBI:167625) has role platelet aggregation inhibitor (CHEBI:50427) |
| droxicam (CHEBI:76133) has role platelet aggregation inhibitor (CHEBI:50427) |
| edoxaban (CHEBI:85973) has role platelet aggregation inhibitor (CHEBI:50427) |
| edoxaban tosylate (CHEBI:85975) has role platelet aggregation inhibitor (CHEBI:50427) |
| edoxaban tosylate hydrate (CHEBI:85974) has role platelet aggregation inhibitor (CHEBI:50427) |
| EET (CHEBI:64007) has role platelet aggregation inhibitor (CHEBI:50427) |
| eptifibatide (CHEBI:291902) has role platelet aggregation inhibitor (CHEBI:50427) |
| forskolin (CHEBI:42471) has role platelet aggregation inhibitor (CHEBI:50427) |
| galgravin (CHEBI:132648) has role platelet aggregation inhibitor (CHEBI:50427) |
| herquline A (CHEBI:229724) has role platelet aggregation inhibitor (CHEBI:50427) |
| herquline B (CHEBI:66012) has role platelet aggregation inhibitor (CHEBI:50427) |
| hydroxysafflor yellow A (CHEBI:139030) has role platelet aggregation inhibitor (CHEBI:50427) |
| iloprost (CHEBI:63916) has role platelet aggregation inhibitor (CHEBI:50427) |
| isobavachalcone (CHEBI:28106) has role platelet aggregation inhibitor (CHEBI:50427) |
| isotanshinone IIB (CHEBI:66098) has role platelet aggregation inhibitor (CHEBI:50427) |
| LFM-A13 (CHEBI:183517) has role platelet aggregation inhibitor (CHEBI:50427) |
| lificiguat (CHEBI:142430) has role platelet aggregation inhibitor (CHEBI:50427) |
| methyl brevifolincarboxylate (CHEBI:66711) has role platelet aggregation inhibitor (CHEBI:50427) |
| milrinone (CHEBI:50693) has role platelet aggregation inhibitor (CHEBI:50427) |
| milrinone lactate (CHEBI:34850) has role platelet aggregation inhibitor (CHEBI:50427) |
| miroprofen (CHEBI:76249) has role platelet aggregation inhibitor (CHEBI:50427) |
| ML355 (CHEBI:195557) has role platelet aggregation inhibitor (CHEBI:50427) |
| neobavaisoflavone (CHEBI:66614) has role platelet aggregation inhibitor (CHEBI:50427) |
| nisoldipine (CHEBI:7577) has role platelet aggregation inhibitor (CHEBI:50427) |
| oleoyl danshenxinkun A (CHEBI:66819) has role platelet aggregation inhibitor (CHEBI:50427) |
| oleoyl neocryptotanshinone (CHEBI:66820) has role platelet aggregation inhibitor (CHEBI:50427) |
| procainamide (CHEBI:8428) has role platelet aggregation inhibitor (CHEBI:50427) |
| prostaglandin E1 (CHEBI:15544) has role platelet aggregation inhibitor (CHEBI:50427) |
| resolvin D5 (CHEBI:138645) has role platelet aggregation inhibitor (CHEBI:50427) |
| sapinmusaponin Q (CHEBI:66169) has role platelet aggregation inhibitor (CHEBI:50427) |
| sapinmusaponin R (CHEBI:66170) has role platelet aggregation inhibitor (CHEBI:50427) |
| sciadopitysin (CHEBI:9050) has role platelet aggregation inhibitor (CHEBI:50427) |
| selexipag (CHEBI:90844) has role platelet aggregation inhibitor (CHEBI:50427) |
| sevoflurane (CHEBI:9130) has role platelet aggregation inhibitor (CHEBI:50427) |
| SKF-96365 hydrochloride (CHEBI:145121) has role platelet aggregation inhibitor (CHEBI:50427) |
| sophoraflavanone B (CHEBI:50207) has role platelet aggregation inhibitor (CHEBI:50427) |
| splitomicin (CHEBI:75272) has role platelet aggregation inhibitor (CHEBI:50427) |
| surfactin (CHEBI:29681) has role platelet aggregation inhibitor (CHEBI:50427) |
| surfactin C (CHEBI:71978) has role platelet aggregation inhibitor (CHEBI:50427) |
| syringetin (CHEBI:18215) has role platelet aggregation inhibitor (CHEBI:50427) |
| taiwanin C (CHEBI:191411) has role platelet aggregation inhibitor (CHEBI:50427) |
| tetramethylpyrazine (CHEBI:133246) has role platelet aggregation inhibitor (CHEBI:50427) |
| ticagrelor (CHEBI:68558) has role platelet aggregation inhibitor (CHEBI:50427) |
| ticlopidine (CHEBI:9588) has role platelet aggregation inhibitor (CHEBI:50427) |
| treprostinil (CHEBI:50861) has role platelet aggregation inhibitor (CHEBI:50427) |
| troglitazone (CHEBI:9753) has role platelet aggregation inhibitor (CHEBI:50427) |
| VAS2870 (CHEBI:233997) has role platelet aggregation inhibitor (CHEBI:50427) |
| vinigrol (CHEBI:222218) has role platelet aggregation inhibitor (CHEBI:50427) |
| vitexin (CHEBI:16954) has role platelet aggregation inhibitor (CHEBI:50427) |
| vorapaxar (CHEBI:82702) has role platelet aggregation inhibitor (CHEBI:50427) |
| vorapaxar sulfate (CHEBI:83314) has role platelet aggregation inhibitor (CHEBI:50427) |
| xenocyloin (CHEBI:156365) has role platelet aggregation inhibitor (CHEBI:50427) |
| yinyanghuo A (CHEBI:66492) has role platelet aggregation inhibitor (CHEBI:50427) |
| yinyanghuo B (CHEBI:66493) has role platelet aggregation inhibitor (CHEBI:50427) |
| β-benzoyloxypaeoniflorin (CHEBI:132791) has role platelet aggregation inhibitor (CHEBI:50427) |
| δ-guaiene (CHEBI:63447) has role platelet aggregation inhibitor (CHEBI:50427) |
| partial prostacyclin agonist (CHEBI:51577) is a platelet aggregation inhibitor (CHEBI:50427) |
| platelet glycoprotein-IIb/IIIa receptor antagonist (CHEBI:50433) is a platelet aggregation inhibitor (CHEBI:50427) |